预测心脏和脏对萨库比特里尔/瓦尔萨坦的反应,使用心力衰竭的数学模型来预测心脏和脏的反应
在PubMed上查看摘要
概括
此摘要是机器生成的。通过降低心脏压力和NT-proBNP,萨库比特里尔/ 瓦尔萨坦 (ARNI) 在心脏衰竭中具有前景. 然而,该模型表明可能存在风险,因此需要对慢性病 (CKD) 等并发症患者进行进一步的研究.
科学领域
- 心脏病学
- 肝脏病学
- 生理学
- 药理学
背景情况
- 常见的是心力衰竭 (HFpEF),通常与高血压 (HTN) 和慢性病 (CKD) 一起发生.
- 这些并发症显著增加了HFpEF患者的心血管 (CV) 发病率和死亡率.
- 目前治疗的有效性和安全性在HFpEF和CKD等并发症中仍然不完全理解.
研究的目的
- 在HFpEF中研究心脏和脏在萨库比特里尔/瓦尔萨坦 (ARNI) 治疗期间的详细生理反应.
- 通过复杂的生理模型,比较ARNI与血管激素受体阻断剂 (ARB) 单一治疗的效果.
- 阐明ARNI对同时患有CKD的HFpEF患者的影响.
主要方法
- 使用人类生理学的大型数学模型HumMod.
- 在HFpEF模型中模拟了对ARNI和ARB的36周治疗反应.
- 分析心脏压力的预测变化,左心室质量,血压,NT-proBNP和的参数.
主要成果
- 与ARB相比,ARNI治疗预测心脏压力,左心室壁应力和质量,血压和NT-proBNP的降低更大.
- 模型模拟表明ARNI增加了淋巴细胞高血压,白膜尿和脏损伤.
- 尽管膜过率提高,心脏质量减少,但这些效应发生不论盐的摄入量如何.
结论
- 在HFpEF中,ARNI治疗对心脏重塑和血压控制有潜在的益处,与临床试验结果一致.
- 该生理模型预测了ARNI在HFpEF中的潜在不良效应,特别是在CKD的背景下.
- 进一步的研究和仔细的终点选择对于评估伴随疾病的HFpEF患者的长期心血管和脏结果至关重要.
相关概念视频
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

